American Society of Plastic Surgeons logo
Connecticut OFFICE

2 Greenwich Office Park
Suite 210
Greenwich, CT 06831
203 863-0003

Greenwich Hospital Office

77 Lafayette Place
Suite 302
Greenwich, CT 06830
203 863-0003

Dutchess County Office

21 Reade Place

Suite 2100
Poughkeepsie, NY 12601
203 863-0003

Bronx Office

2425 Eastchester Road
Bronx, NY 10469

News

Anaplastic Large Cell Lymphoma In Women with Breast Implants: Preliminary FDA Findings & Analyses

Posted Date: January 26, 2011

Reports in the scientific community have suggested a possible association between anaplastic large cell lymphoma (ALCL) and breast implants.

Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses
Executive Summary

Reports in the scientific community have suggested a possible association between anaplastic large cell lymphoma (ALCL) and breast implants. In its January 2011 report, the FDA summarizes the scientific data the Agency used to assess the possible association. It represents the FDA’s current understanding, based on the published scientific literature on ALCL in women with breast implants and information gathered through the FDA’s contact with other regulatory authorities, scientific experts, and breast implant manufacturers. The document includes the FDA’s analyses of the data and steps it plans to take to better understand and characterize the possible association.

The report, Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses, is published on the FDA website

PLEASE ENTER YOUR PORTAL LOGIN


CANCEL